New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 9, 2021 - Seagen and Astellas Pharma announced the regular FDA approval and expanded indication for Padcev (enfortumab vedotin-ejfv).
Download PDF
Return to publications
